Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/261709
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Liquid biopsy: a non-invasive approach for Hodgkin lymphoma genotyping |
Autor: | Alcoceba, Miguel; García-Alvarez, María; Chillón, M. del Carmen; Jiménez, Cristina; Medina, Alejandro; Antón, Alicia; Blanco, Óscar; Díaz, Luis G.; Tamayo, Pilar; González-Calle, Verónica; Vidal, María Jesús; Cuello, Rebeca; Díaz Gálvez, Francisco Javier; Queizán, José-Antonio; Martín, Alejandro; González, Marcos CSIC ORCID ; García-Sanz, Ramón; Sarasquete, María Eugenia | Palabras clave: | Hodgkin lymphoma Liquid biopsy Circulating tumour DNA Next generation sequencing |
Fecha de publicación: | nov-2021 | Editor: | John Wiley & Sons | Citación: | British Journal of Haematology 195(14): 542-551 (2021) | Resumen: | The Hodgkin lymphoma (HL) genomic landscape is hardly known due to the scarcity of tumour cells in the tissue. Liquid biopsy employing circulating tumour DNA (ctDNA) can emerge as an alternative tool for non-invasive genotyping. By using a custom next generation sequencing (NGS) panel in combination with unique molecule identifiers, we aimed to identify somatic variants in the ctDNA of 60 HL at diagnosis. A total of 277 variants were detected in 36 of the 49 samples (73·5%) with a good quality ctDNA sample. The median number of variants detected per patient was five (range 1–23) with a median variant allele frequency of 4·2% (0·84–28%). Genotyping revealed somatic variants in the following genes: SOCS1 (28%), IGLL5 (26%), TNFAIP3 (23%), GNA13 (23%), STAT6 (21%) and B2M (19%). Moreover, several poor prognosis features (high LDH, low serum albumin, B-symptoms, IPI ≥ 3 or at an advanced stage) were related to significantly higher amounts of ctDNA. Variant detection in ctDNA by NGS is a feasible approach to depict the genetic features of HL patients at diagnosis. Our data favour the implementation of liquid biopsy genotyping for the routine evaluation of HL patients. | Versión del editor: | http://dx.doi.org/10.1111/bjh.17719 | URI: | http://hdl.handle.net/10261/261709 | DOI: | 10.1111/bjh.17719 | ISSN: | 0007-1048 | E-ISSN: | 1365-2141 |
Aparece en las colecciones: | (IBMCC) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
accesoRestringido.pdf | 15,38 kB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
SCOPUSTM
Citations
15
checked on 26-abr-2024
WEB OF SCIENCETM
Citations
11
checked on 25-feb-2024
Page view(s)
79
checked on 28-abr-2024
Download(s)
9
checked on 28-abr-2024
Google ScholarTM
Check
Altmetric
Altmetric
NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.